Trials / Completed
CompletedNCT04747158
COVID-19 Convalescent Plasma Therapy
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 350 (actual)
- Sponsor
- Universidad Nacional de Asunción · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label trial in which hospitalized patients with risk factors of severe coronavirus disease 2019 \[COVID-19\] will be receive treatment with convalescent plasma (≤ 15 days from symptoms start).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Convalescent plasma | COVID-19 convalescent plasma at admission, after confirmation of eligibility, 200 ml on day 1 and 2 |
Timeline
- Start date
- 2020-08-10
- Primary completion
- 2020-12-10
- Completion
- 2021-01-10
- First posted
- 2021-02-10
- Last updated
- 2021-03-02
Locations
1 site across 1 country: Paraguay
Source: ClinicalTrials.gov record NCT04747158. Inclusion in this directory is not an endorsement.